Processa pharmaceuticals to present at the world orphan drug congress usa, august 25-27

Hanover, md, aug. 23, 2021 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa), a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have an unmet medical need condition today announced it will present at the world orphan drug congress usa 2022 conference, to be held from august 25-27, 2022.
PCSA Ratings Summary
PCSA Quant Ranking